Sign in to follow
Search Results

0 results for 'Boehringer Ingelheim'

You can use to get even better search results
May 15, 2019 | Litigation Daily

AbbVie, Boehringer Settle Humira Patent Fight

Under the agreement, Boehringer will to pay AbbVie royalties for licensing its Humira patents and agreed to acknowledges the validity and enforceability of the patents, AbbVie said.
3 minute read
May 15, 2019 | Delaware Business Court Insider

AbbVie, Boehringer Settle Humira Patent Dispute in U.S.

Under the agreement, Boehringer will to pay AbbVie royalties for licensing its Humira patents and agreed to acknowledges the validity and enforceability of the patents, AbbVie said.
3 minute read
May 14, 2019 | Law.com

Skilled in the Art: Pharma Patents: The Good, the Bad, and the Vaguely Familiar + FTC Cracks on DOJ

Three pharma patent bombs exploded this week, and we have a look at the law firms on the front lines.
9 minute read
May 07, 2019 | Daily Business Review

Half Full? South Florida Plaintiff Leads Asthma Inhaler Class Action

The lawsuit against Boehringer Ingelheim Pharmaceuticals claims its Combivent Respimat inhaler offers far fewer doses than advertised.
3 minute read
May 07, 2019 | Connecticut Law Tribune

Class Action Claims Boehringer Ingelheim Misled Users About Popular Asthma Inhaler

Connecticut-based Boehringer Ingelheim Pharmaceuticals Inc. has been hit with a prospective class action lawsuit that alleges its Combivent asthma inhaler provides far less than the number of advertised doses.
3 minute read
April 30, 2019 | Corporate Counsel

Becoming A Business Leader

For general counsel, legal risks aren't the only factor. Gaining a seat at the table means learning the business and bringing solutions rather than a blanket 'no.'
8 minute read
March 15, 2019 | Law.com

JD, Meh! Here's What It Really Takes to Make It as a GC

Being an effective GC requires more than being a skilled lawyer. It takes business savvy.
2 minute read
February 28, 2019 | Corporate Counsel

Tesla, CBS and United See New General Counsel: February 2019 In-House Moves

A roundup of major in-house moves occurring in February.
11 minute read
February 27, 2019 | The American Lawyer

Revenue, Partner Profits Hit New Highs at Paul Hastings

Chairman Seth Zachary outlined a strategy that's simple, at least on its face: Win more work, and more complex work.
4 minute read
February 14, 2019 | Litigation Daily

Daily Dicta: Wilmer, Latham Lawyers Swatted in Red-Hot Discovery Fight over World's Best-Selling Drug

A fed-up magistrate judge in Delaware ordered pharma giant AbbVie to turn over requested discovery materials to Boehringer Ingelheim in a patent fight over Humira, the world's best-selling drug.
6 minute read

More from ALM

More from ALM

Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

Resources

  • Good Legal Technology is Good Business: A Case for Bringing Employment Issues In-House

    Brought to you by LexisNexis®

    Download Now

  • Insights and Strategies for Effective Succession Planning in AM Law 100 Firms

    Brought to you by Gallagher

    Download Now

  • State AI Legislation Is on the Move in 2024

    Brought to you by LexisNexis®

    Download Now

  • 2024 ESI Risk Management & Litigation Readiness Report

    Brought to you by Pagefreezer

    Download Now

NEXT